
- Telehealth visits
- Insurance plan information

Rebecca Michael, MD
Neurology • Neurology (Headache Medicine)- Telehealth visits
- Insurance plan information



Rebecca Michael, MD
Neurology • Neurology (Headache Medicine)- Telehealth visits
- Insurance plan information
On this page
Education & training
Board certification
- Psychiatry & Neurology, American Board of Psychiatry and Neurology
Fellowship
- Head and Facial Pain, Cleveland Clinic Main Campus
Residency
- Neurology, Cleveland Clinic Main Campus
Internship
- Internal Medicine, Cleveland Clinic Main Campus
Degree
- MD, University of Nevada School of Medicine -Las Vegas
Academic title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 51 reviews
- August 30, 20265 out of 5 Stars
Dr Michael, thank you for the continued EXCELLENT care!!
- August 29, 20265 out of 5 Stars
The doctor listened attentively and understood my symptoms well, so I was well informed about which direction to choose for the next consultation.
- July 11, 20265 out of 5 Stars
They were friendly, listened attentively to the patient's explanation, answered my questions well, and explained everything thoroughly.
- June 25, 20265 out of 5 Stars
Dr Michael is caring and compassionate. She listens attentively and patiently to my concerns. She responds and communicates with respect. I appreciate her very much.
- June 24, 20265 out of 5 Stars
Dr. Michael is amazing she takes excellent care of me, my needs and my overall wellbeing.
- May 15, 20265 out of 5 Stars
Thank you for the excellent care Dr Michael!
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.